89 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
MS drug developer Kyverna Therapeutics files for $100M IPO https://seekingalpha.com/news/4055843-ms-drug-developer-kyverna-therapeutics-files-for-100m-ipo?source=feed_sector_healthcare Jan 17, 2024 - Kyverna Therapeutics (KYTX), which is developing therapies for autoimmune disorders such as lupus and multiple sclerosis, has filed for a proposed $100M IPO. Read more here.
MS Emerging Markets Debt Fund Review: Emerging Market Bonds Outlook 2024 https://seekingalpha.com/article/4664214-msd-emerging-market-bonds-outlook-2024?source=feed_tag_etf_portfolio_strategy Jan 22, 2024 - MSD is a closed-ended fixed-income fund focused on emerging markets, aiming for high income and some capital appreciation. Click here to read my analysis.
Do Investors Have Too Much Money Out of the Market? https://www.fool.com/investing/2024/01/28/do-investors-have-too-much-money-out-of-the-market/?source=iedfolrf0000001 Jan 28, 2024 - We've also got a look at two stocks worth watching: Globus Medical and RPM International.
Contineum Therapeutics Seeks $150 Million IPO For MS Treatments https://seekingalpha.com/article/4679126-contineum-therapeutics-seeks-150-million-ipo-for-ms-treatments?source=feed_tag_ipo_analysis Mar 19, 2024 - Contineum Therapeutics plans to raise $150 million through an IPO for developing advanced medical treatments, with strong institutional support and a key...
Clene stock rallies 52% post-market on MS drug data https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
Morgan Stanley (MS) Q2 2024 Earnings Call Transcript https://seekingalpha.com/article/4704396-morgan-stanley-ms-q2-2024-earnings-call-transcript?source=feed_sector_transcripts Jul 16, 2024 - Morgan Stanley (NYSE:NYSE:MS) Q2 2024 Earnings Conference Call July 16, 2024 9:30 AM ETCompany ParticipantsTed Pick - CEOSharon Yeshaya - CFOConference Call...
Why ASML Holdings Fell Today https://www.fool.com/investing/2024/09/20/why-asml-holdings-fell-again-today/?source=iedfolrf0000001 Sep 20, 2024 - After yesterday's interest rate-fueled surge, another analyst is stepping to the sidelines.
Why PepsiCo Stock Lost Its Fizz on Friday https://www.fool.com/investing/2024/09/20/why-pepsico-stock-lost-its-fizz-on-friday/?source=iedfolrf0000001 Sep 20, 2024 - One pundit tracking the company is particularly concerned about the performance of its foundational snacks business.
MS India Investment Fund declares $3.1357 dividend https://seekingalpha.com/news/4043667-ms-india-investment-fund-declares-31357-dividend?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Dec 05, 2023 - MS India Investment Fund (IIF) declares total dividend of $3.1357/share, including STCG 0.2847, LTCG 2.851 dividend. Payable Jan. 12; for shareholders of record
Morgan Stanley (MS) Q4 2023 Earnings Call Transcript https://seekingalpha.com/article/4663111-morgan-stanley-ms-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Jan 16, 2024 - Morgan Stanley (NYSE:NYSE:MS) Q4 2023 Earnings Conference Call January 16, 2024 8:30 AM ETCompany ParticipantsTed Pick - CEOSharon Yeshaya - CFOConference...

Pages: 123456...9

Page 1>